Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Revelation Biosciences, Inc.
Market Cap
$2.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.86M
Net Profit Margin
-427.67%
TTM Avg
-455.53%
3Y Avg
-478.79%
5Y Avg
-375.12%
Market Cap
$3.07M
Net Profit Margin
0.00%
TTM Avg
-9993.13%
3Y Avg
-11306.74%
5Y Avg
-8768.57%
Market Cap
$3.14M
Net Profit Margin
-3089.55%
TTM Avg
-3099.32%
3Y Avg
-6095.20%
5Y Avg
-22555.36%
Market Cap
$2.69M
Net Profit Margin
-2449.04%
TTM Avg
-339.09%
3Y Avg
-222.12%
5Y Avg
-170.97%
Market Cap
$3.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-523.72%
5Y Avg
-1138.73%
Market Cap
$2.66M
Net Profit Margin
-20.56%
TTM Avg
-29.23%
3Y Avg
-24.83%
5Y Avg
-8.51%
Market Cap
$3.28M
Net Profit Margin
-87.20%
TTM Avg
-5303.47%
3Y Avg
-2728.60%
5Y Avg
-1828.05%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $2.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | -427.67% | -455.53% | -478.79% | -375.12% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.00% | -9993.13% | -11306.74% | -8768.57% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | -3089.55% | -3099.32% | -6095.20% | -22555.36% |
| iSpecimen Inc. (ISPC)vs › | $2.69M | -2449.04% | -339.09% | -222.12% | -170.97% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.00% | 0.00% | -523.72% | -1138.73% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | -20.56% | -29.23% | -24.83% | -8.51% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | -87.20% | -5303.47% | -2728.60% | -1828.05% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -4139.38% | -3617.24% | -2890.13% | -2863.43% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
